Delivery Order SPE2DB24D3013-SPE2DB25FFQMB
- Not listed
- The Defense Logistics Agency awarded a delivery order valued at $10,859.04 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on September 11, 2025, with an ultimate completion date of September 12, 2025. The pharmaceutical product will be delivered to Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate...
- The Defense Logistics Agency awarded a delivery order valued at $3,850.74 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed-price delivery order was issued on July 31, 2025, with an ultimate completion date of August 1, 2025, and will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. This delivery...
- The Defense Logistics Agency awarded a $13,817.08 delivery order to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used in the treatment of chronic obstructive pulmonary disease. This competitively awarded, firm fixed price contract was issued on July 28, 2025, with an ultimate completion date of July 29, 2025. The place of performance is the contractor's corporate office location in Conshohocken, Pennsylvania. This delivery order is...
- The Defense Logistics Agency awarded a delivery order valued at $12,077.82 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used primarily for chronic obstructive pulmonary disease management. The competitively awarded, firm fixed-price delivery order was issued on July 30, 2025, with an ultimate completion date of July 31, 2025. The contract performs in Conshohocken, Pennsylvania, at the vendor's corporate office location. This...
- The Defense Logistics Agency awarded a delivery order valued at $2,888.15 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract, awarded on August 25, 2025, with an ultimate completion date of August 26, 2025, utilizes firm fixed pricing and carries no set-aside designation, indicating it was competitively awarded. AmerisourceBergen Drug Corp, headquartered in Conshohocken,...
- The Defense Logistics Agency awarded a delivery order valued at $8,409.03 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25 60S, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The competitively awarded, firm fixed-price delivery order was placed on August 8, 2025, with an ultimate completion date of August 11, 2025. Performance will be executed from AmerisourceBergen's corporate office located in Conshohocken, Pennsylvania. This...
- The Defense Logistics Agency awarded a delivery order valued at $6,085.54 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The non-set-aside, firm fixed price contract was awarded on August 13, 2025, with an ultimate completion date of August 14, 2025. This delivery order represents a single pharmaceutical transaction executed under AmerisourceBergen's broader federal procurement...
- The Defense Logistics Agency awarded a delivery order valued at $1,637.52 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 100-62.5-25, a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The award was made on July 21, 2025, with an ultimate completion date of July 22, 2025, and represents a firm fixed price, non-set-aside contract. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania. This delivery order...
- The Defense Logistics Agency awarded a delivery order valued at $42,051.91 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder used to treat chronic obstructive pulmonary disease. The contract, awarded on August 22, 2025, with an ultimate completion date of August 25, 2025, utilizes firm fixed pricing with no set-aside designation. Performance will occur at the contractor's Conshohocken, Pennsylvania facility, where AmerisourceBergen maintains its...
- The Defense Logistics Agency awarded a Delivery Order valued at $16,547.64 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25, a combination inhalation powder used for chronic obstructive pulmonary disease management. The competitively awarded contract, which was not set aside for any specific business category, is firm fixed price and was executed on September 11, 2025, with an ultimate completion date of September 12, 2025. The product will be performed and delivered from...
- SPE2DB24D3013Indefinite Delivery Contract
- SPE2DB24D3013-SPE2DB25FFQMBDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $3,890.36 to AmerisourceBergen Drug Corp for TRELEGY ELLIPTA 200-62.5-25 (60-count supply), a combination inhalation powder medication used to treat chronic obstructive pulmonary disease. The contract was awarded on September 11, 2025, with an ultimate completion date of September 12, 2025, and represents a firm fixed price delivery order with no set-aside designation. Performance will occur at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's broader Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), a $999,999,999 global pharmaceutical support vehicle extending through December 2026. AmerisourceBergen is a major pharmaceutical distributor serving critical federal medical procurement needs, particularly for military and veteran healthcare systems. The company's DLA contract enables comprehensive pharmaceutical supply across multiple therapeutic domains, supporting military healthcare programs worldwide and customers including the Defense Health Agency and U.S. Coast Guard.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.9k | 9/11/25 |